Skip to main content
The Texas Heart Institute Journal logoLink to The Texas Heart Institute Journal
. 2013;40(4):449–452.

First Case of Fusobacterium necrophorum Endocarditis To Have Presented after the 2nd Decade of Life

Curtiss Moore 1, Daniel Addison 1, James M Wilson 1, Barry Zeluff 1
PMCID: PMC3783136  PMID: 24082377

Abstract

Fusobacterium necrophorum, an obligate, anaerobic, filamentous, gram-negative rod, is thought to be a normal inhabitant of the mucous membranes in human beings. Fusobacterium species have been implicated in cases of Lemierre syndrome and other pathologic conditions. Their reported association with infective endocarditis is extremely rare.

We describe the case of a previously healthy 34-year-old man who emergently presented with flu-like symptoms and dyspnea on exertion. He had recently undergone a dental procedure. Empiric antibiotic therapy was initiated. Blood cultures were positive for metronidazole-resistant F. necrophorum. A transesophageal echocardiogram revealed 2 mobile vegetations on the mitral valve. Despite the antibiotic therapy, the patient's respiratory status worsened and, after 3 weeks, he died. On the basis of the organism's pathophysiology and the patient's recent dental procedure, the oral cavity was the likely source of the bacteremia.

Our patient's case underscores the importance of recognizing Fusobacterium bacteremia as a possible cause of endocarditis. To our knowledge, this is the first reported case of monomicrobial F. necrophorum endocarditis to have presented in a patient after the 2nd decade of life. In addition, it is apparently only the 4th report of F. necrophorum mitral valve endocarditis with case results derived from modern culture techniques.

Key words: Anti-bacterial agents/therapeutic use; endocarditis, bacterial/complications/drug therapy/etiology; fatal outcome; fusobacterium infections/blood/diagnosis/drug therapy; fusobacterium necrophorum

Fusobacterium necrophorum is an obligate, anaerobic, filamentous, gram-negative rod that frequently colonizes the human respiratory tract, gastrointestinal tract, and mouth. Fusobacterium species have been implicated in cases of Lemierre syndrome, meningitis, orbital cellulitis, necrotizing pneumonia, septic arthritis, and systemic infections.1,2 We describe what appears to be the first reported case of monomicrobial F. necrophorum endocarditis in a patient 30 years of age or older. In addition, we list the documented cases of monomicrobial Fusobacterium endocarditis.

Case Report

A previously healthy 34-year-old man emergently presented with a one-week history of fever, chills, myalgias, abdominal pain, and dyspnea on exertion. He had been evaluated at a local clinic one week earlier for a presumed upper respiratory tract infection, and azithromycin had been prescribed. He had recently undergone an elective dental procedure. Despite the oral antibiotic therapy, his flu-like symptoms had progressed. Upon his admission to the emergency department, 4 blood cultures were obtained, and empiric therapy with intravenous vancomycin, ceftriaxone, and metronidazole was begun. After he was admitted to the hospital, all 4 blood cultures were reported to be positive for metronidazole-resistant F. necrophorum. The patient was continued on ceftriaxone therapy for gram-negative rod sepsis. Computed tomograms of his neck revealed an incidental parietal-lobe hypodensity without other acute pathologic indications. Subsequent images showed a subacute infarct involving the left occipital and parietal lobes. A transesophageal echocardiogram revealed 2 mobile vegetations on the mitral valve, and the diagnosis was F. necrophorum infective endocarditis.

The patient's fever and bacteremia persisted despite maximal antibiotic therapy, and his course was complicated by acute respiratory distress syndrome that necessitated intubation. His respiratory status worsened, and after 3 weeks, he died.

Discussion

Our review of the medical literature revealed 15 prior verifiable cases of monomicrobial Fusobacterium infective endocarditis (Table I).1,4–17 To our knowledge, ours is the first documented case of F. necrophorum endocarditis to have presented after the 2nd decade of life.

TABLE I. Summary of Reported Cases of Fusobacterium Endocarditis

graphic file with name 18TT1A.jpg

TABLE I, continued. Summary of Reported Cases of Fusobacterium Endocarditis

graphic file with name 18TT1B.jpg

In reports of presumed gram-negative anaerobic endocarditis from before 1950 or so, the culprit organisms could not always be reliably identified. The chief reasons were inadequate microbiological detail and confusion pertaining to nomenclature.18 The comparatively unsophisticated anaerobic culture methods of earlier eras led to misattributed causation by streptococci and other organisms18; and, historically, F. necrophorum has probably been known by more than 50 names.19 Accordingly, ours is apparently only the 4th report of F. necrophorum endocarditis with case results derived from modern culture techniques.

Fusobacterium septicemia, a rare form of gram-negative sepsis, characteristically presents with high fever, pharyngitis, and submandibular adenopathy.2 Fusobacterium necrophorum is classically associated with Lemierre syndrome (ipsilateral jugular vein thrombosis) after oropharyngeal trauma.2 Very infrequently, the pathogen has been implicated in clinical cases of endocarditis. In a review of 48 cases of endocarditis caused by gram-negative anaerobic organisms (reported from 1940 through 1996), Bisharat and colleagues20 determined that dental caries were implicated in 12 of the 35 cases in which an infection source was suggested. The results of our patient's physical examination and imaging studies were not consistent with an acute oropharyngeal pathologic condition. Nevertheless, on the basis of the known pathophysiology of the organism and the patient's recent dental procedure, it is reasonable to implicate the oral cavity as the source of the bacteremia.

Regardless of its source, Fusobacterium bacteremia is best treated by means of combination therapy consisting of a 3rd-generation cephalosporin and additional anaerobic coverage. In our patient, the unsuccessful response to therapy was attributed to an increased resistance to metronidazole. This case underscores the importance of recognizing Fusobacterium bacteremia as a possible cause of endocarditis after disruption of the oropharyngeal mucosa.

Footnotes

Address for reprints: Daniel Addison, MD, Department of Cardiology, Baylor College of Medicine, 6620 Main St., 11D 32.1, Houston, TX 77030

E-mail: addison@bcm.tmc.edu

References

  • 1.Augusto JF, Mercat A, Asfar P, Pinaud F, Croue A, Chausseret L. Fatal case of Fusobacterium necrophorum mitral endocarditis. J Infect 2010;61(1):94–5. [DOI] [PubMed]
  • 2.Lemierre A. On certain septicaemias due to anaerobic organisms. Lancet 1936;227(5874):701–3.
  • 3.Felner JM, Dowell VR Jr. Anaerobic bacterial endocarditis. N Engl J Med 1970;283(22):1188–92. [DOI] [PubMed]
  • 4.Nastro LJ, Finegold SM. Endocarditis due to anaerobic gram-negative bacilli. Am J Med 1973;54(4):482–96. [DOI] [PubMed]
  • 5.Seggie J. Fusobacterium endocarditis treated with metronidazole. Br Med J 1978;1(6118):960–1. [DOI] [PMC free article] [PubMed]
  • 6.Sapico FL, Sarma RJ. Infective endocarditis due to anaerobic and microaerophilic bacteria. West J Med 1982;137(1):18–23. [PMC free article] [PubMed]
  • 7.Adams J, Capistrant T, Crossley K, Johanssen R, Liston S. Fusobacterium necrophorum septicemia. JAMA 1983;250(1):35. [PubMed]
  • 8.Gonzalez Cocina E, Espinosa Caliani JS, Cabrerizo Comitre E, Arana Romero C, Perez Peinado M, Gonzalez Santos P. Endocarditis derecha por fusobacterium nucleatum [in Spanish]. Rev Esp Cardiol 1991;44(3):207–9. [PubMed]
  • 9.Epstein M, Pearson AD, Hudson SJ, Bray R, Taylor M, Beesley J. Necrobacillosis with pancytopenia. Arch Dis Child 1992;67(7):958–9. [DOI] [PMC free article] [PubMed]
  • 10.Stuart G, Wren C. Endocarditis with acute mitral regurgitation caused by Fusobacterium necrophorum. Pediatr Cardiol 1992;13(4):230–2. [DOI] [PubMed]
  • 11.Shammas NW, Murphy GW, Eichelberger J, Klee D, Schwartz R, Bachman W. Infective endocarditis due to Fusobacterium nucleatum: case report and review of the literature. Clin Cardiol 1993;16(1):72–5. [DOI] [PubMed]
  • 12.Weber G, Borer A, Riesenberg K, Schlaeffer F. Infective endocarditis due to Fusobacterium nucleatum in an intravenous drug abuser. Eur J Clin Microbiol Infect Dis 1999;18(9):655–7. [DOI] [PubMed]
  • 13.Goolamali SI, Carulli MT, Davies UM. Spinal abscess and mitral valve endocarditis secondary to asymptomatic fusobacterium-induced dental abscess. J R Soc Med 2006;99(7):368–9. [DOI] [PMC free article] [PubMed]
  • 14.Vedire S, Alpert MA, Ren J, Manian FA. Fusobacterium necrophorum endocarditis in a previously healthy young adult. Am J Med Sci 2007;334(2):125–7. [DOI] [PubMed]
  • 15.De Socio GV, Mencacci A, Bini P, Pasticci MB. Fusobacterium nucleatum endocarditis mimicking polymyalgia rheumatica. South Med J 2009;102(10):1082–4. [DOI] [PubMed]
  • 16.Samant JS, Peacock JE Jr. Fusobacterium necrophorum endocarditis. Case report and review of the literature. Diagn Microbiol Infect Dis 2011;69(2):192–5. [DOI] [PubMed]
  • 17.Handler MZ, Miriovsky B, Gendelman HE, Sandkovsky U. Fusobacterium necrophorum causing infective endocarditis and liver and splenic abscesses. Rev Inst Med Trop Sao Paolo 2011;53(3):169–72. [DOI] [PubMed]
  • 18.Riordan T. Human infection with Fusobacterium necrophorum (necrobacillosis), with a focus on Lemierre's syndrome. Clin Microbiol Rev 2007;20(4):622–59. [DOI] [PMC free article] [PubMed]
  • 19.Finegold SM. Anaerobic bacteria in human disease. New York: Academic Press; 1977. p. 13–4.
  • 20.Bisharat N, Goldstein L, Raz R, Elias M. Gram-negative anaerobic endocarditis: two case reports and review of the literature. Eur J Clin Microbiol Infect Dis 2001;20(9):651–4. [DOI] [PubMed]

Articles from Texas Heart Institute Journal are provided here courtesy of Texas Heart Institute

RESOURCES